Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.793 GBX | -6.71% | -0.88% | -50.44% |
26/04 | Evgen Pharma plc will Change its Ticker to TCF from EVG | CI |
26/04 | Evgen Pharma plc will Change its Name to TheraCryf plc | CI |
Chart calendar Theracryf Plc
Upcoming events on Theracryf Plc
Past events on Theracryf Plc
04/04/2024 02:30 pm | Shareholders Meeting |
20/03/2024 03:30 pm | Acquisition of Chronos Therapeutics Limited by Evgen Pharma Plc Call |
08/01/2024 | JPMorgan Healthcare Conference |
14/11/2023 | Jefferies London Healthcare Conference |
13/11/2023 07:15 pm | LSX Inv€$stival Showcase |
31/10/2023 12:30 pm | Q2 2024 Earnings Release |
20/07/2023 08:30 pm | Investor Meeting |
20/07/2023 06:30 pm | Annual General Meeting |
07/06/2023 11:30 am | Q4 2023 Earnings Release |
23/03/2023 07:30 pm | SFX-01 Phase 1b Study Results Call |
23/03/2023 | Proactive One2One Investor Forum |
08/12/2022 07:30 pm | Interim 2023 Earnings Call |
08/12/2022 12:30 pm | Interim 2023 Earnings Release |
12/10/2022 05:30 pm | Investor Meeting |
21/07/2022 08:00 pm | Investor Meeting |
21/07/2022 06:30 pm | Annual General Meeting |
08/06/2022 11:30 am | FY 2022 Earnings Release |
07/12/2021 12:30 pm | Interim 2022 Earnings Release |
13/07/2021 06:30 pm | Annual General Meeting |
15/06/2021 11:30 am | FY 2021 Earnings Release |
Annual results
Fiscal Period | Marzo | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,27 0,27 0.27% | 0,00 0,00 - | 0,55 0,61 -9.46% | 0,49 |
EBITDA Million USD | Released Forecast Spread | -3,94 -4,29 8.1% | -3,95 -4,34 8.93% | -4,51 -5,05 10.71% | -4,00 -6,42 37.75% | -6,32 -4,72 -33.78% | -4,98 |
EBIT Million USD | Released Forecast Spread | -3,97 -4,29 7.48% | -3,97 -4,34 8.33% | -4,53 -5,19 12.56% | -4,02 -6,40 37.29% | -6,34 -4,72 -34.12% | -4,98 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,97 -4,55 12.76% | -3,97 -4,60 13.57% | -4,53 -5,32 14.79% | -3,99 -6,55 39.11% | -6,21 -4,97 -25.14% | -5,10 |
Net income Million USD | Released Forecast Spread | -3,34 -3,90 14.41% | -3,41 -3,94 13.52% | -3,77 -4,50 16.21% | -3,43 -5,54 38% | -5,02 -4,24 -18.4% | -4,37 |
EPS USD | Released Forecast Spread | -0,03 -0,04 13.49% | -0,03 -0,03 12.74% | -0,03 -0,03 14.46% | -0,01 -0,02 38.03% | -0,02 -0,02 -15.87% | -0,02 |
Announcement Date | 13/06/19 | 15/06/20 | 15/06/21 | 08/06/22 | 07/06/23 | - |
Today 01:35 am | EXELIXIS, INC.: Q1 2024 Earnings Release |
01/05/2024 | SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release |
01/05/2024 | MACROGENICS, INC.: Q1 2024 Earnings Release (Projected) |
01/05/2024 | REGENXBIO INC.: Q1 2024 Earnings Release (Projected) |
01/05/2024 | DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
01/05/2024 04:30 pm | NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release |
02/05/2024 01:35 am | SAREPTA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
02/05/2024 | ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
02/05/2024 | DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
02/05/2024 | GERON CORPORATION: Q1 2024 Earnings Release |
Past sector events for Theracryf Plc
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EVG Stock
- Calendar Theracryf Plc